Ⅰ期子宫内膜癌初次治疗采用放疗和激素治疗与长期生存的关系
研究基于美国国家癌症数据库2004至2016年数据,纳入112,469例临床Ⅰ期子宫内膜样腺癌女性,其中2776例(3%)接受非手术治疗。非手术治疗组5年生存率为40%,子宫切除组为89%,非手术治疗组死亡风险显著更高(HR 7.6)。作者认为选择非手术治疗时应谨慎。
要点
- Ⅰ期子宫内膜样腺癌非手术治疗者5年生存率40%,子宫切除者为89%。
- 非手术治疗与更高死亡风险相关(HR 7.6,95%CI 7.2-8.0,p<0.001)。
- 高龄、黑人种族、较高Charlson-Deyo评分、医疗补助保险及机构年子宫切除量低与非手术治疗相关。
核心结论
- 与子宫切除相比,Ⅰ期子宫内膜样腺癌接受非手术治疗者死亡风险显著更高,选择非手术治疗时应谨慎。
研究设计与样本
- 基于美国国家癌症数据库2004至2016年的回顾性队列研究,纳入112,469例45岁以上临床Ⅰ期子宫内膜样腺癌女性。
- 非手术治疗组与初始子宫切除组比较,采用logistic回归分析非手术治疗相关因素,采用log-rank检验、Kaplan-Meier曲线及Cox比例风险回归(含和不含倾向性评分匹配)分析总生存。
主要发现
- 2776例(3%)接受非手术治疗,其中1987例(71%)接受放疗,688例(25%)接受激素治疗,101例(4%)接受两者。
- 非手术治疗组5年生存率为40%(95%CI 37%-42%),子宫切除组为89%(95%CI 88%-89%)。
- 非手术治疗组死亡速率快于初始子宫切除组(HR 7.6,95%CI 7.2-8.0;p<0.001),该差异在校正Cox模型和倾向性评分匹配后仍具统计学显著性。
- 高龄、黑人种族、较高Charlson-Deyo评分、医疗补助保险及机构年子宫切除量低与非手术治疗相关。
临床怎么用
- 作者认为,鉴于非手术治疗结局更差,选择非手术治疗患者时应谨慎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Estimate the association between non-surgical management (NSM) (e.g. hormonal or radiation therapy) and overall survival among women with stage I endometrioid endometrial cancer (EEC) and identify patient and facility characteristics associated with receipt of NSM. METHODS: Women >45 years of age with clinical stage I EEC were identified in the National Cancer Database from 2004 to 2016. Women treated with NSM were compared with women treated initially with hysterectomy. Patient and facility characteristics associated with NSM were evaluated using logistic regression models. Association with overall survival was examined using log-rank tests, Kaplan-Meier curves, and Cox proportional hazards regression models with and without propensity score matching (PSM). RESULTS: A total of 112,469 women underwent treatment for stage I EEC between 2004 and 2016. 2776 (3%) received NSM, of whom 1987 (71%) received radiation therapy, 688 (25%) received hormonal therapy, and 101 (4%) received both. Older age, black race, higher Charlson-Deyo scores, Medicaid insurance, and low annual facility hysterectomy volume were associated with receiving NSM. The 5-year survival rate was 40% (95%CI: 37%-42%) for women with NSM compared to 89% (95%CI: 88%-89%) for hysterectomy. Women treated with NSM died at a faster rate than those who underwent primary hysterectomy (HR 7.6, 95%CI: 7.2-8.0; p < 0.001). This statistically significant difference in survival persisted in adjusted Cox proportional hazards models and after PSM. CONCLUSIONS: Women treated with NSM had a significantly higher risk of death compared to those undergoing hysterectomy for stage I EEC. Caution should be used when selecting patients for NSM given its worse outcomes.
引用
- Pyrzak A, Chen L, Kocherginsky M, et al. Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival. Gynecol Oncol. 2020. PMID: 32553589. doi:10.1016/j.ygyno.2020.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。